top of page

6 signals every clinical AI approach should capture.

After working across multiple clinical programmes, we identified
6 critical points that are often overlooked - and that can materially impact decision-making.

Scroll down⌄

Where These Signals Translate Into Clinical Decisions

Are you missing a responder subgroup? 

Population heterogeneity

Was the right dose found for the right patients? 

Dose Optimisation

Did you measure the right thing at the right time? 

Endpoint Timing 

Is there information hidden un your adverse event data? 

Safety Signals

Does the order of therapy matter in your indication? 

Treatment Sequencing 

What is your trial data telling you about biology? 

MoA Insights

Join Our Team

We’re looking for highly-motivated and talented people to join our innovative team. Submit your application today to join the BGS journey!

Senior Project Manager

San Francisco, CA

Associate Director, Drug Delivery

San Francisco, CA

Data Scientist, IT

San Francisco, CA

Press

BGS appoints Andrew Kim as Board Director

AGIAI Science Journal
November 2035

Therapeutics Giant Announces Collaboration With San Francisco’s BGS

Biotech Frontier Review
May 2035

There’s a New Kid in Town, Changing the Face of Genetic Engineering.

IBRM Magazine
March 2035

Download instantly. 

No fluff, an actionable checklist. 

bottom of page